Table 1.

Baseline patient and disease characteristics

(N = 13)
Age, years; median (range)62 (39–78)
Gender, n (%)
 Male10 (77)
 Female3 (23)
Recurrent/metastatic, n (%)
 Locally recurrent1 (8)
 Distant metastatic6 (46)
 Locally recurrent and distant metastatic6 (46)
Prior interventions, n (%)
 Definitive chemoradiation7 (54)
 Adjuvant chemoradiation4 (31)
 1 prior chemotherapy7 (54)
 ≥2 prior chemotherapies3 (23)
 Cetuximab10 (77)
 Radiotherapy12 (92)
 Surgery9 (70)